Kees Bol
Kees Bol publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Glycosylation and Glycoproteins Research.
- World rank
- #3,271,312 of 7,710,434 ranked researchers
- Rank in Netherlands
- #65,779 of 107,149
- Works
- 21
- Citations
- 880
- Citations per work
- 41.9
What does Kees Bol research?
Kees Bol's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (16%), Materials Science (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1151.0%
- Medicine1151.0%
- Everything else417.7%
- Life Sciences315.7%
- Physical Sciences315.6%
- Materials Science27.8%
- Chemistry13.9%
- Energy13.9%
- 1Oncology29% of their works
- 2Radiology, Nuclear Medicine and Imaging22% of their works
- 3Molecular Biology16% of their works
- 4Materials Chemistry8% of their works
- 5Physical and Theoretical Chemistry4% of their works
- 6Renewable Energy, Sustainability and the Environment4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- HER2/EGFR in Cancer Research
- Glycosylation and Glycoproteins Research
- Advanced Physical and Chemical Molecular Interactions
- Chemical and Physical Properties of Materials
- Advanced Materials and Semiconductor Technologies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
Which keywords describe Kees Bol's research?
The keywords of their largest research topics: Glycosylation, Fc Receptors, Therapeutic Antibodies, Breast Cancer, HER2, Cancer, Chemotherapy-Induced Peripheral Neuropathy and Computational Chemistry.
- Taxanes
- PD-1 and PD-L1
- Nanomaterials Synthesis
- Immune Checkpoint Blockade
- Computational Chemistry
- Cancer
- Breast Cancer
- Fc Receptors
- Glycosylation
- Therapeutic Antibodies
- HER2
- Chemotherapy-Induced Peripheral Neuropathy
- Glycans
- Molecular Simulation
- Nanoparticles
- Synthesis
- Thin-Film Deposition
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Glycosylation102 topics
- Fc Receptors81 topic
- Therapeutic Antibodies81 topic
- Breast Cancer71 topic
- HER271 topic
- Cancer21 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Computational Chemistry21 topic
- Glycans21 topic
- Immune Checkpoint Blockade21 topic
- Molecular Simulation21 topic
- Nanomaterials Synthesis21 topic
- Nanoparticles21 topic
- PD-1 and PD-L121 topic
- Synthesis21 topic
- Taxanes21 topic
- Thin-Film Deposition21 topic
Where does Kees Bol work?
Kees Bol's main affiliation in the publication record is Merus (Netherlands), Netherlands.
How many publications and citations does Kees Bol have?
OpenAlex counts 21 works and 880 citations for Kees Bol, an h-index of 9, ranking #3,271,312 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kees Bol. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.